Erenapursta (E3330) is a direct, orally active and selective inhibitor of Ape-1 (apurinic/apyrimidinic endonuclease 1)/Ref-1 (redox factor-1) redox. Erenapursta is able to impair tumor growth and blocks the activity of NF-kappaB, AP-1, and HIF-1alpha in pancreatic cancer. Erenapursta shows anticancer activities[1][2][3][4][5].
Molekulargewicht:
378.46
Reinheit:
99.67
CAS Nummer:
[136164-66-4]
Formel:
C21H30O6
Target-Kategorie:
AP-1,DNA/RNA Synthesis,HIF/HIF Prolyl-Hydroxylase,NF-kappaB,Reactive Oxygen Species (ROS),VEGFR
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten